An FDA panel just rejected MDMA assisted therapy. We look at the reasons why, and what this means for the future of psychedelic therapy. CME: Take the CME Post-Test for this EpisodePublished On: 06/17/2024Duration: 25 minutes, 59 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Did boundary violations sink MDMA assisted psychotherapy? We explore the reasons behind the FDA panel’s rejection of this psychedelic therapy.CME: Take the CME Post-Test for this EpisodePublished On: 06/10/2024Duration: 20 minutes, 01 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In today's episode, Dr. DePhilippis tells us all about Contingency Management: what it is, how it works, and its evidence for the treatment of stimulant use disorders.CME: Take the CME Post-Test for this EpisodePublished On: 06/03/2024Duration: 43 minutes, 29 secondNoah Capurso, MD, Dominick DePhilippis, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Clinicians who have lived with mental illness share how it impaired them - and strengthenedthem - on the job.CME: Take the CME Post-Test for this EpisodePublished On: 05/27/2024Duration: 21 minutes, 50 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As we delved into Carl Jung's archetype of the wounded healer last Monday, it reminded us of something we learned about the serotonin transporter gene. Has modern genetics discovered a pathway to the archetype? You be the judge in this throwback to a 2021 episode. CME: Take the CME Post-Test for this EpisodePublished On: 05/20/2024Duration: 22 minutes, 31 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Clinicians who have lived with mental illness show us how to build a deeper empathy from our past wounds, starting with Carl Jung.CME: Take the CME Post-Test for this EpisodePublished On: 05/13/2024Duration: 11 minutes, 14 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Clinicians who live with mental illness share the do’s and don’t’s of self-disclosureCME: Take the CME Post-Test for this EpisodePublished On: 05/06/2024Duration: 21 minutes, 46 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
14 clinicians with mental illness share how they ask patients about mania, depression, psychosis, OCD, panic disorder, addiction, trauma, and suicide.CME: Take the CME Post-Test for this EpisodePublished On: 04/29/2024Duration: 20 minutes, 08 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
What steps should clinicians take if psychopharmacologic treatments and school behavioral strategies are insufficient for managing a child with ADHD? We've all been there. ADHD, attention deficit hyperactivity disorder, of course, affects millions of children and adolescents worldwide and can significantly impact focus, impulses, and engagement with friends.Parents and caregivers need to understand the different kinds of medications and therapies that are available to help manage ADHD. In this podcast, Mara and I will explore the various treatment options for ADHD in children and discuss how to navigate the process of selecting more effective treatments.Published On: 04/22/2024Duration: 26 minutes, 43 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options. CME: Take the CME Post-Test for this EpisodePublished On: 04/15/2024Duration: 30 minutes, 43 secondNoah Capurso, MD, Brian Hurley, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Does psychiatry keep making the same mistakes? Edward Shorter gives us a historical perspective. CME: Take the CME Post-Test for this EpisodePublished On: 04/08/2024Duration: 22 minutes, 16 secondChris Aiken, MD, Edward Shorter, PhD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.CME: Take the CME Post-Test for this EpisodePublished On: 04/01/2024Duration: 12 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
All sorts of medications are prescribed for anxiety in older adults. Today, we look at when and how to discontinue them.CME: Take the CME Post-Test for this EpisodePublished On: 03/25/2024Duration: 22 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Today we are discussing dissociative identity disorder (DID) and related topics Published On: 03/18/2024Duration: 17 minutes, 31 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Today, I am discussing narcissistic personality with Dr. Frank Yeomans, a world leader in the psychotherapy of personality disorders.Published On: 03/11/2024Duration: 31 minutes, 17 secondsMark Ruffalo, MSW, DPsa and Frank Yeomans, MD, PhD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity
Today, Avoidant/Restrictive Food Intake Disorder (ARFID) and its treatmentmodalities in the world of mental health are explored.Published On: 03/04/2024Duration: 17 minutes, 23 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Today, we will be discussing the challenges of managing antipsychotic medications in children and adolescents. We will explore various strategies that aim to balance symptom relief with potential side effects, while also guiding towards personalized and safer treatment options. Join us in discovering the art of precision in pediatric mental health care.Published On: 02/26/2024Duration: 19minutes, 25 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Here's a Throwback Thursday episode originally cast in March of 2021, where we're going to look at the question of whether adding a z hypnotic improves antidepressant response. And stay tuned to the very end where I'm going to update it with new research. We all know that when you sleep better, you feel better.CME: Take the CME Post-Test for this EpisodePublished On: 02/22/2024Duration: 27 minutes, 56 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dosing is not a collaborative venture when it comes to controlled substances, and here we look for the safe upper limits of stimulant dosing.CME: Take the CME Post-Test for this EpisodePublished On: 02/19/2024Duration: 22 minutes, 23 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants, benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case.Today, in part one of a two-part series, we'll open up a forgotten repository of psychiatric research, where a stack of about 50 controlled trials has been archived away, suggesting that the GABAergic benzos might actually treat depression.CME: Take the CME Post-Test for this EpisodePublished On: 02/15/2024Duration: 27 minutes, 43 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
ID21376211
I am a prospective Psych NP student, and I plan to recommend this podcast to every mental health practitioner I can! The content is packaged in well-produced, bite-sized pieces for a busy student/nurse as myself. Thank you to the Carlat Psychiatry team for producing great content about psychopharmacology that is unaffiliated with pharmaceutical bias!